Literature DB >> 19956452

Real time PCR detection of the PI*Z and PI*S mutations associated with alpha-1 antitrypsin deficiency.

Claudine L Bartels, Angela L Marchetti, W Edward Highsmith, Gregory J Tsongalis.   

Abstract

Alpha-1 antitrypsin (A1AT or AAT) is a serine protease inhibitor (PI) which, when present at low levels, can cause chronic obstructive pulmonary disease (COPD) and liver disease in both children and adults. Several mutations within the SERPINA1 gene have been found to cause this deficiency. The most common variants are PI*Z and PI*S, each caused by a single nucleotide polymorphism (SNP). We describe a real time polymerase chain reaction (PCR) assay for the rapid genotyping of these polymorphisms. DNA was extracted from fourteen EDTA-anticoagulated whole blood samples using the Qiagen EZ1 blood extraction kit. SNP genotyping was performed using primer/probe sets purchased from Applied Biosystems. These were evaluated for performance and assay conditions on the Applied Biosystems 7500 FAST System. The genotypes of these samples were compared with their phenotype results from isoelectric focusing assays, which were performed by an independent reference laboratory. In addition, twenty samples that were previously genotyped at another laboratory were obtained for accuracy studies. Thirty-four samples were tested; five genotypes were represented and the assay was able to discriminate these successfully. Only one genotype could not be correlated with its phenotype result, as the phenotype was reported as an "unidentified allele". All other genotyping results were concordant with previously determined genotypes and phenotypes. We describe a rapid real time PCR assay that is suitable for clinical use in genotyping AAT alleles and which can be used as the initial step in A1AT testing algorithms.

Entities:  

Keywords:  Real-time PCR; alpha-1 antitrypsin; chronic obstructive pulmonary disease (COPD); genotyping; molecular diagnostics; serine protease inhibitor; single nucleotide polymorphism (SNP)

Year:  2009        PMID: 19956452      PMCID: PMC2780033     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  20 in total

Review 1.  Alpha one antitrypsin deficiency: from gene to treatment.

Authors:  Alice M Wood; Robert A Stockley
Journal:  Respiration       Date:  2007       Impact factor: 3.580

2.  The mechanism of Z alpha 1-antitrypsin accumulation in the liver.

Authors:  D A Lomas; D L Evans; J T Finch; R W Carrell
Journal:  Nature       Date:  1992-06-18       Impact factor: 49.962

Review 3.  The Pi system-inherited variants of serum alpha 1-antitrypsin.

Authors:  M K Fagerhol; C B Laurell
Journal:  Prog Med Genet       Date:  1970

4.  Diagnosis of alpha-1-antitrypsin deficiency: An algorithm of quantification, genotyping, and phenotyping.

Authors:  Melissa R Snyder; Jerry A Katzmann; Malinda L Butz; Carmen Wiley; Ping Yang; D Brian Dawson; Kevin C Halling; W Edward Highsmith; Stephen N Thibodeau
Journal:  Clin Chem       Date:  2006-10-19       Impact factor: 8.327

Review 5.  Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

6.  Serum alpha 1-antitrypsin deficiency associated with the common S-type (Glu264----Val) mutation results from intracellular degradation of alpha 1-antitrypsin prior to secretion.

Authors:  D T Curiel; A Chytil; M Courtney; R G Crystal
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

Review 7.  Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency.

Authors:  David H Perlmutter
Journal:  Pediatr Res       Date:  2006-08       Impact factor: 3.756

8.  Alpha-1 antitrypsin Null mutations and severity of emphysema.

Authors:  Laura Fregonese; Jan Stolk; Rune R Frants; Barbera Veldhuisen
Journal:  Respir Med       Date:  2008-03-18       Impact factor: 3.415

Review 9.  Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency.

Authors:  M Luisetti; N Seersholm
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

Review 10.  An overview of the serpin superfamily.

Authors:  Ruby H P Law; Qingwei Zhang; Sheena McGowan; Ashley M Buckle; Gary A Silverman; Wilson Wong; Carlos J Rosado; Chris G Langendorf; Rob N Pike; Philip I Bird; James C Whisstock
Journal:  Genome Biol       Date:  2006-05-30       Impact factor: 13.583

View more
  4 in total

1.  Alpha₁-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis.

Authors:  Alfred D Mahr; Jeffrey C Edberg; John H Stone; Gary S Hoffman; E William St Clair; Ulrich Specks; Paul F Dellaripa; Philip Seo; Robert F Spiera; Farshid N Rouhani; Mark L Brantly; Peter A Merkel
Journal:  Arthritis Rheum       Date:  2010-12

Review 2.  The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung Diseases.

Authors:  Gillian A Kelly-Robinson; James A Reihill; Fionnuala T Lundy; Lorcan P McGarvey; John C Lockhart; Gary J Litherland; Keith D Thornbury; S Lorraine Martin
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

3.  Exogenous alpha 1-antitrypsin down-regulates SERPINA1 expression.

Authors:  Ahmad Karadagi; Helene Johansson; Helen Zemack; Sandeep Salipalli; Lisa-Mari Mörk; Kristina Kannisto; Carl Jorns; Roberto Gramignoli; Stephen Strom; Knut Stokkeland; Bo-Göran Ericzon; Danny Jonigk; Sabina Janciauskiene; Greg Nowak; Ewa C S Ellis
Journal:  PLoS One       Date:  2017-05-09       Impact factor: 3.240

4.  IMP1 regulates UCA1-mediated cell invasion through facilitating UCA1 decay and decreasing the sponge effect of UCA1 for miR-122-5p.

Authors:  Yanchun Zhou; Xiuhua Meng; Shaoying Chen; Wei Li; Delin Li; Robert Singer; Wei Gu
Journal:  Breast Cancer Res       Date:  2018-04-18       Impact factor: 6.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.